Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Phase 4 Study of 0.05% Cyclosporine Eye Drops II for Perioperative Dry Eye
ChiCTR2600117578Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of cyclosporine in dry eye syndrome (DED) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Tear Film Breakup Time (TBUT). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2600117578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117578.